Christophe Mossé appointed as CEO of Arkopharma group
He will oversee Arkopharma’s activities and related activities of Dermapharm Group.
Brings industry expertise from leading groups: Naos, Galderma, Novartis,…
Founded in 1980 in Carros, near Nice, Arkopharma is a pharmaceutical laboratory specialized in phytotherapy, natural medicines, and dietary supplements.
Arkopharma, a European leader in its field, has announced the arrival of Christophe Mossé as CEO (cf. LinkedIn post below)
Christophe Mossé brings a wealth of experience in the pharmaceutical industry, both in France and internationally.
With his expertise, Christophe Mossé will lead Arkopharma’s activities and related operations of Dermapharm Group, and will be the main link between the management teams of the two entities.
Arkopharma is now present in more than 60 countries and is positioned as the European leader in phytotherapy medicines and dietary supplements.
With 1,212 employees and a consolidated turnover of 201 million euros, Arkopharma dedicates 8.5% of its workforce to research and development, with 1,635 registrations and marketing authorizations for medicines.
Health Nice Côte d’Azur
- Vascular Surgery at Nice University Hospital: A New, Innovative Piece of Equipment
- MyHealthFriend: a Franco-Italian app for preventive health and well-being
- LifeSciences Afterwork in Monaco: Team Nice Côte d’Azur Strengthens the Region’s Health Sector Connections
- Circum Medtech Pharma expands its industrial development in Tunisia from Nice
- Japan Entry Acceleration Program: a launchpad towards the Japanese market for innovative health startups
- TIGER e-health: the Côte d’Azur integrates into alpine innovation
- The Nice-based biotech Roca Therapeutics reaches a new milestone in its development
- Team Nice Côte d’Azur on a mission at the International Congress of Nutrition 2025
- Horus Pharma accelerates its international expansion across 8 new countries
- Health Afterwork in Nice: connecting innovators in the HealthTech sector
